Lee A L, Kim Y S, Lim B J, Jeong H J, Joo D J, Kim M S, Huh K H
Department of Surgery, Yonsei University College of Medicine, Seoul, Korea; The Research Institute for Transplantation, Yonsei University College of Medicine, Seoul, Korea.
Transplant Proc. 2013 Oct;45(8):2937-40. doi: 10.1016/j.transproceed.2013.08.081.
In contrast with deceased donor transplantation, the clinical significance of pathologic findings in time-zero biopsies after living donor kidney transplantation are rarely reported, due to the expectation that histologic findings and renal function are normal. The aim of this study was to identify subclinical pathologic findings in living donors and examine the effect on early graft renal function.
Between December 2006 and July 2011, 146 living-donor kidney transplant recipients were enrolled in this study. We retrospectively analyzed donor and recipient-related clinical parameters, and post-transplant 6 months and 1 year estimated glomerular filtration rate (eGFR) as early graft renal function. Time-zero biopsies were evaluated using the 2007 Banff criteria.
Most abnormal histologic findings were of mild degree as determined by Banff scores. Global glomerulosclerosis (GS, 35.6%), tubular atrophy (CT, 36.3%), interstitial fibrosis (CI, 20.5%), vascular fibrous intimal thickening (CV, 4.1%), arteriolar hyaline thickening (AH, 14.4%), interstitial inflammation (I, 3.4%) were pathologic findings in time-zero biopsies. The univariate analysis revealed that donor age and gender were significantly associated with eGFR at post-transplant 6 months and at 1 year (P < .05). Furthermore, GS and CT were significantly associated with early graft renal function (P < .05). However, multivariate linear regression analysis showed only donor age was significantly associated with early graft renal function (P = .001).
A mild degree of subclinical, pathologic findings on time-zero biopsy did not affect early graft renal function in living-donor kidney transplantation.
与尸体供肾移植不同,活体供肾移植术后即刻活检病理结果的临床意义鲜有报道,因为人们预期组织学检查结果和肾功能均正常。本研究旨在确定活体供者的亚临床病理结果,并探讨其对移植肾早期肾功能的影响。
2006年12月至2011年7月,146例活体供肾移植受者纳入本研究。我们回顾性分析了供者和受者相关的临床参数,以及移植后6个月和1年的估计肾小球滤过率(eGFR)作为移植肾早期肾功能指标。采用2007年Banff标准对即刻活检进行评估。
根据Banff评分,大多数异常组织学表现为轻度。即刻活检的病理结果包括全球肾小球硬化(GS,35.6%)、肾小管萎缩(CT,36.3%)、间质纤维化(CI,20.5%)、血管纤维内膜增厚(CV,4.1%)、小动脉玻璃样增厚(AH,14.4%)、间质炎症(I,3.4%)。单因素分析显示,供者年龄和性别与移植后6个月和1年的eGFR显著相关(P <.05)。此外,GS和CT与移植肾早期肾功能显著相关(P <.05)。然而,多因素线性回归分析显示只有供者年龄与移植肾早期肾功能显著相关(P = .001)。
活体供肾移植术中即刻活检发现的轻度亚临床病理结果不影响移植肾早期肾功能。